Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EYE | Common Stock | Options Exercise | $315K | +20K | +297.62% | $15.74 | 26.7K | Jul 28, 2021 | Direct | |
transaction | EYE | Common Stock | Sale | -$1.07M | -20K | -74.85% | $53.50 | 6.72K | Jul 28, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EYE | Stock Option (Right to Buy) | Options Exercise | $0 | -20K | -28.77% | $0.00 | 49.5K | Jul 28, 2021 | Common Stock | 20K | $15.74 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 2, 2021. This sale was the final transaction under this Rule 10b5-1 trading plan. |
F2 | These shares include 2,220 shares that were acquired pursuant to the Company's Associate Stock Purchase Plan, which acquisitions are exempt from Section 16. |
F3 | Of the 49,510 stock options reported herein, 33,236 stock options are vested and the remaining 16,274 time-based stock options will vest on in equal installments on August 14, 2021 and August 14, 2022. |